comparemela.com

Page 17 - Ben Atwell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HUTCHMED Highlights Phase III FRESCO-2 MRCT Data Summary of

PureTech Health: PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022

LYT-100 was well-tolerated compared to pirfenidone in a healthy older adult crossover trial, informing dose selection for recently initiated trial in IPF PureTech Health plc (Nasdaq: PRTC, LSE:

HUTCHMED (China) (HCM) to Present Additional Fruquintinib MRCT FRESCO-2 Data

HUTCHMED (China) (HCM) to Present Additional Fruquintinib MRCT FRESCO-2 Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.